Zhejiang Yatai Pharmaceutical (002370.SZ): Spironolactone tablets pass the consistency evaluation of quality and efficacy for generic drugs.
Asia-Pacific Pharmaceutical (002370.SZ) announced that it has recently received the "Drug Supplement Application Approval Notification" issued by the National Medical Products Administration for spironolactone tablets. The company's spironolactone tablets have passed the consistency evaluation of quality and efficacy for generic drugs. Spironolactone tablets are indicated for the treatment of edematous diseases, hypertension, primary hyperaldosteronism, and the prevention of hypokalemia.
Zhejiang Yatai Pharmaceutical (002370.SZ) announced that the company has recently received the "Approval Notification for Drug Supplement Application" regarding spironolactone tablets, issued by the National Medical Products Administration. The companys spironolactone tablets have passed the consistency evaluation of quality and efficacy for generic drugs. Spironolactone tablets are indicated for the treatment of edema, hypertension, primary hyperaldosteronism, and the prevention of hypokalemia.
The successful consistency evaluation of spironolactone tablets will further enrich the companys product pipeline, enhance the market competitiveness of this drug, and accumulate experience for the companys future consistency evaluation work on other products.
Related Articles
HK Stock Market Move | LEGEND HOLDING (03396) rose over 6% following a positive earnings forecast, expecting a net profit attributable to equity holders in the first half to increase by no less than 186% year-on-year.
HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.
HK Stock Market Move | TAI HING GROUP (06811) rose over 8% after announcing a profit alert, expecting a net profit attributable to shareholders of approximately HKD 72 million to HKD 78 million for the first half of the year.
HK Stock Market Move | LEGEND HOLDING (03396) rose over 6% following a positive earnings forecast, expecting a net profit attributable to equity holders in the first half to increase by no less than 186% year-on-year.
HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.
HK Stock Market Move | TAI HING GROUP (06811) rose over 8% after announcing a profit alert, expecting a net profit attributable to shareholders of approximately HKD 72 million to HKD 78 million for the first half of the year.
RECOMMEND
